The notion that “pure” ALS and “pure” frontotemporal dementia (FTD) may present two extremes of one disease continuum [19] is reinforced by identification of transactive response DNA-binding protein 43 (TDP-43) as a major pathological substrate underlying both diseases [20]. The gene discussed is TARDBP; the disease is frontotemporal dementia.